Fulton Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Fulton Bank's CRL Position: Q2 2025 in Review
Fulton Bank sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 2,228 shares — an estimated $335K sold.
Fulton Bank first reported a position in CRL in Q4 2020 and held it in 18 quarters. The position peaked at $853K in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.
- Fulton Bank reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
- Fulton Bank sold 2,228 Charles River Laboratories shares in Q2 2025, an estimated $335K.
- Fulton Bank first reported a position in Charles River Laboratories in Q4 2020 and held it in 18 quarters.
- Fulton Bank's Charles River Laboratories position peaked at $853K in Q1 2024.
- 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.
Based on Fulton Bank's 13F filing for Q2 2025, filed 10 Jul 2025.